相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The substrates and binding partners of protein kinase Cε
Philip M. Newton et al.
BIOCHEMICAL JOURNAL (2010)
Regulation of Prostate Cancer Cell Survival by Protein Kinase Cε Involves Bad Phosphorylation and Modulation of the TNFα/JNK Pathway
John Meshki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
Paolo Gandellini et al.
CANCER RESEARCH (2009)
Protein kinase Cε: an oncogene and emerging tumor biomarker
Michael A. Gorin et al.
MOLECULAR CANCER (2009)
Rationally designed peptide regulators of protein kinase C
Eric N. Churchill et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Role of GL12 transcription factor in growth and tumorigenicity of prostate cells
Saravanan Thiyagarajan et al.
CANCER RESEARCH (2007)
Protein kinase Cε makes the life and death decision
Alakananda Basu et al.
CELLULAR SIGNALLING (2007)
Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis
Dae Joon Kim et al.
MOLECULAR CARCINOGENESIS (2007)
Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer
L. Tam et al.
BRITISH JOURNAL OF CANCER (2007)
Protein kinase Cε is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner
Kyung-Mi Bae et al.
CANCER RESEARCH (2007)
Protein kinase Cε, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3
Moammir H. Aziz et al.
CANCER RESEARCH (2007)
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner et al.
NATURE REVIEWS CANCER (2007)
Protein kinase Cε activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-α-induced cell death
Dongmei Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B-Raf and S6K2
Olivier E. Pardo et al.
EMBO JOURNAL (2006)
Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis
C Zhong et al.
CANCER RESEARCH (2006)
Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy
Q Pan et al.
CANCER RESEARCH (2005)
Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning
L Barandon et al.
CIRCULATION RESEARCH (2005)
Functional proteomic analysis of a three-tier PKCε-Akt-eNOS signaling module in cardiac protection
J Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Mutation of the androgen receptor causes oncogenic transformation of the prostate
GZ Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee
SB Shappell et al.
CANCER RESEARCH (2004)
Protein kinase C and prostate carcinogenesis: Targeting the cell cycle and apoptotic mechanisms
MV Gavrielides et al.
CURRENT DRUG TARGETS (2004)
Integrin signaling links protein kinase Cε to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells
DQ Wu et al.
ONCOGENE (2004)
Protein kinase Cε interacts with Bax and promotes survival of human prostate cancer cells
MA McJilton et al.
ONCOGENE (2003)
Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway
Y Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inorganic arsenite-induced malignant transformation of human prostate epithelial cells
WE Achanzar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
MJ Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCα
ML Garcia-Bermejo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras-1
S Kampfer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo
JF Zhang et al.
ENDOCRINOLOGY (2000)
The ε subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation
BW Doble et al.
CIRCULATION RESEARCH (2000)
Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia
ML Rodriguez-Puebla et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
